In breast cancer cells, ATM expression has been linked to upregulated miR-18a, which also inhibits the formation of nuclear foci by downstream substrates H2AX and p53-binding protein 1 (53BP1) [82]. This evidence concerns the gene TP53BP1 and breast carcinoma.